We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$133B
AUM Growth
+$2.97B
(+2.3%)
Cap. Flow
+$494M
Cap. Flow
% of AUM
0.37%
Top 10 Holdings %
Top 10 Hldgs %
28.35%
Holding
293
New
7
Increased
75
Reduced
134
Closed
7
Avg Time Held
3.4
years
Top 10 Avg Time Held
3.7
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$635M |
| 2 |
United Airlines
UAL
|
+$620M |
| 3 |
Qualcomm
QCOM
|
+$401M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$302M |
| 5 |
Whirlpool
WHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$442M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$411M |
| 3 |
Adobe
ADBE
|
+$359M |
| 4 |
Texas Instruments
TXN
|
+$345M |
| 5 |
AT&T
T
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.7% |
| 2 | Healthcare | 23.28% |
| 3 | Industrials | 16.25% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Financials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
EOG Resources
EOG
$80.1B
| $227M | 0.17% |
2,159,437
-25,413
| -1% | -$2.74M |
2013 Q2
19 quarters
|
|
102
Xencor
XNCR
$1.78B
| $224M | 0.17% |
7,475,643
+1,317,400
| +21% | +$34.4M |
2013 Q4
17 quarters
|
|
103
Dell
DELL
$301B
| $215M | 0.16% |
10,467,243
-109,980
| -1% | -$2.37M |
2016 Q3
6 quarters
|
|
104
Mastercard
MA
$540B
| $213M | 0.16% |
1,217,024
+79,124
| +7% | +$13.5M |
2013 Q2
19 quarters
|
|
105
DELISTED
Praxair Inc
PX
| $211M | 0.16% |
1,464,369
-16,001
| -1% | -$2.49M |
2013 Q2
19 quarters
|
|
|
VMW
106
DELISTED
VMware, Inc
VMW
| $210M | 0.16% |
1,735,707
+56,600
| +3% | +$7.13M |
2013 Q2
19 quarters
|
|
107
CVS Health
CVS
$118B
| $210M | 0.16% |
3,377,691
-16,042
| -0.5% | -$1.15M |
2013 Q2
19 quarters
|
|
108
Chegg
CHGG
$84.4M
| $208M | 0.16% |
10,045,390
-150,000
| -1% | -$2.84M |
2014 Q1
16 quarters
|
|
|
MFGP
109
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $203M | 0.15% |
11,928,434
+1,215,616
| +11% | +$39.9M |
2017 Q3
2 quarters
|
|
110
Comscore
SCOR
$61.2M
| $192M | 0.14% |
399,223
+95,826
| +32% | +$46.1M |
2013 Q2
19 quarters
|
|
|
TRCO
111
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $191M | 0.14% |
4,703,590
-44,400
| -0.9% | -$1.87M |
2014 Q4
13 quarters
|
|
112
Merck
MRK
$358B
| $186M | 0.14% |
3,574,938
-2,267,733
| -39% | -$122M |
2014 Q4
13 quarters
|
|
113
MarketAxess Holdings
MKTX
$5.79B
| $181M | 0.14% |
834,420
-25,000
| -3% | -$5.14M |
2013 Q2
19 quarters
|
|
114
DELISTED
Sprint Corporation
S
| $179M | 0.13% |
36,624,000
-6,400
| -0% | -$34.2K |
2014 Q3
14 quarters
|
|
115
Las Vegas Sands
LVS
$24.8B
| $172M | 0.13% |
2,392,981
-150,000
| -6% | -$11M |
2013 Q2
19 quarters
|
|
116
Entegris
ENTG
$22.4B
| $168M | 0.13% |
4,820,244
-159,308
| -3% | -$5.39M |
2013 Q2
19 quarters
|
|
117
DuPont de Nemours
DD
$17.8B
| $165M | 0.12% |
1,022,220
-31,591
| -3% | -$5.71M |
2013 Q2
19 quarters
|
|
118
RB Global
RBA
$16.1B
| $162M | 0.12% |
5,154,557
-49,900
| -1% | -$1.59M |
2013 Q2
19 quarters
|
|
119
Curtiss-Wright
CW
$18.5B
| $160M | 0.12% |
1,186,800
-500
| -0% | -$65.3K |
2013 Q3
18 quarters
|
|
120
CSX Corp
CSX
$90.2B
| $159M | 0.12% |
8,585,700
+12,000
| +0.1% | +$224K |
2013 Q2
19 quarters
|
|
|
ABAX
121
DELISTED
Abaxis Inc
ABAX
| $157M | 0.12% |
2,216,300
-1,000
| -0% | -$67.1K |
2013 Q4
17 quarters
|
|
122
Stratasys
SSYS
$624M
| $153M | 0.11% |
7,564,300
| – | – |
2013 Q2
19 quarters
|
|
|
NUAN
123
DELISTED
Nuance Communications, Inc.
NUAN
| $150M | 0.11% |
10,965,430
-1,387,583
| -11% | -$20.3M |
2013 Q2
19 quarters
|
|
|
EPZM
124
DELISTED
Epizyme, Inc
EPZM
| $147M | 0.11% |
8,270,727
-4,600
| -0.1% | -$77.7K |
2013 Q2
19 quarters
|
|
125
DELISTED
Exact Sciences
EXAS
| $144M | 0.11% |
3,579,100
| – | – |
2014 Q2
15 quarters
|
|
Similar funds
Primecap Management's Q1 2018 Portfolio in Review
As of Q1 2018, Primecap Management held 293 positions worth $133B, up 2.3% from $130B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.8%. Primecap Management opened 7 new positions and exited 7, leaving the 293-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2018 buy was Moody's: 181,000 shares worth $29.2M.
- Primecap Management added most to Bristol-Myers Squibb in Q1 2018, an estimated $635M increase.
- Primecap Management's biggest Q1 2018 reduction was NVIDIA, cutting an estimated $442M.
- Primecap Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $411M.
- Primecap Management's ten largest holdings make up 28% of its $133B portfolio in Q1 2018.
- Primecap Management opened 7 new positions and closed 7 in Q1 2018.
- Primecap Management's portfolio value rose 2.3% quarter-over-quarter to $133B.
Based on Primecap Management's 13F filing for Q1 2018, filed 14 May 2018.